123 related articles for article (PubMed ID: 6193365)
1. Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitor.
Baum T; Sybertz EJ; Watkins RW; Ahn HS; Nelson S; Eynon E; Vander Vliet G; Pula KK; Sabin C; Desiderio DM; Becker FT; Vemulapalli S
J Cardiovasc Pharmacol; 1983; 5(4):655-67. PubMed ID: 6193365
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.
Sybertz EJ; Watkins RW; Ahn HS; Baum T; La Rocca P; Patrick J; Leitz F
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S105-8. PubMed ID: 2485040
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Schölkens BA; Becker RH; Kaiser J
Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
Holck M; Fischli W; Hefti F; Gerold M
J Cardiovasc Pharmacol; 1986; 8(1):99-108. PubMed ID: 2419701
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
[TBL] [Abstract][Full Text] [Related]
14. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
Friehe H; Ney P
Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
[TBL] [Abstract][Full Text] [Related]
19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.
Carr RD; Higgs L; Killingback PG; Nicol AK; O'Connor SE; Robson A; Wells E; Simpson WT
Br J Pharmacol; 1990 May; 100(1):83-9. PubMed ID: 2164863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
